You are here: Industry Insights > Aurobindo

News List

Aurobindo Pharma rolls out Molnaflu to treat adult COVID-19 patients ExpressPharma
January 07, 2022
The pill is available pan-India across all major metros and towns
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US expresspharma
March 15, 2021
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation specifications, failed dissolution specifications, presence of foreign tablets, illegible label etc.
Aurobindo Pharma receives USFDA nod for Droxidopa Capsules expresspharma
February 20, 2021
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Droxidopa Capsules, 100 mg, 200 mg and 300 mg. Droxidopa Capsules are generic version of Lundbeck’s Northera Capsules.
Lupin, Aurobindo recall drugs in US market expresspharma
February 18, 2021
Lupin Pharma is recalling 46,479 bottles of Oseltamivir Phosphate for Oral Suspension while AuroMedics Pharma, a unit of Aurobindo Pharma, is recalling 3,094 cartons of Acetaminophen injection.
Aurobindo, KAPL, Kinvan get approval under PLI scheme expresspharma
January 25, 2021
The setting up of plants under the scheme will lead to a total committed investment of Rs 3,761 crore by the companies and employment generation for around 3,825 people, the Ministry of Chemicals and Fertilizers said.
COVAXX, Aurobindo sign Covid-19 vaccine development deal pharmaceutical-technology
December 29, 2020
US company COVAXX has signed an exclusive agreement with Indian company Aurobindo Pharma to expand global development and commercialisation of the former’s multitope peptide-based Covid-19 vaccine, UB-612, to India and the United Nations Children’s Fund.
Aurobindo gets USFDA nod for dexmedetomidine HCL in 0.9% sodium chloride injection expresspharma
December 10, 2020
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 200 µg/50 mL and 400 µg/100 mL Single Dose flexible containers (bags).
Pfizer files patent infringement petition in US court against Aurobindo, Dr Reddy’s expresspharma
November 19, 2020
Alleges that these Indian pharma companies were planning separately to come out with generic versions of its cancer drug Ibrance (palbociclib) before the expiration of its patent.
Indian pharma firms recall medications from US market expresspharma
July 06, 2020
Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders.
Novartis terminates $1bn Sandoz US deal with Aurobindo pharmaceutical-technology
April 03, 2020
Novartis and Aurobindo Pharma USA have signed a mutual agreement to terminate their deal covering the Sandoz US generic oral solids and dermatology businesses.

Previous page 1 2 3 Next page